[U.S. SEC Receives Amended S-1/A Filing for 21Shares Injective ETF] According to Crypto Briefing, the SEC has received an amended S-1/A registration statement for the 21Shares Injective ETF, updating the original filing from October 2025. If approved, the ETF will be listed on Nasdaq under the ticker TINJ, passively tracking the performance of the INJ token through the FTSE Injective Index, with the option to stake a portion of holdings to enhance returns. 21Shares has previously launched an Injective staking ETP in Europe, and this marks an expansion into the U.S. market.